Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 201 entries
Sorted by: Best Match Show Resources per page
Highly enantioselective metallation-substitution alpha to a chiral nitrile.

Chemical science

Sadhukhan A, Hobbs MC, Meijer AJHM, Coldham I.
PMID: 28616143
Chem Sci. 2017 Feb 01;8(2):1436-1441. doi: 10.1039/c6sc03712g. Epub 2016 Oct 25.

We report the deprotonation of a chiral nitrile and reaction of the resulting chiral organometallic species with a variety of electrophiles to give highly enantiomerically enriched 2-substituted nitrile products. The nitrile was treated with TMPMgCl and the resulting anion,...

Cite
Sadhukhan A, Hobbs MC, Meijer AJHM, et al. Highly enantioselective metallation-substitution alpha to a chiral nitrile. Chem Sci. 2016;8(2):1436-1441doi: 10.1039/c6sc03712g.
Sadhukhan, A., Hobbs, M. C., Meijer, A. J. H. M., & Coldham, I. (2017). Highly enantioselective metallation-substitution alpha to a chiral nitrile. Chemical science, 8(2), 1436-1441. https://doi.org/10.1039/c6sc03712g
Sadhukhan, Arghya, et al. "Highly enantioselective metallation-substitution alpha to a chiral nitrile." Chemical science vol. 8,2 (2017): 1436-1441. doi: https://doi.org/10.1039/c6sc03712g
Sadhukhan A, Hobbs MC, Meijer AJHM, Coldham I. Highly enantioselective metallation-substitution alpha to a chiral nitrile. Chem Sci. 2017 Feb 01;8(2):1436-1441. doi: 10.1039/c6sc03712g. Epub 2016 Oct 25. PMID: 28616143; PMCID: PMC5460602.
Copy Download .nbib Format: NLM
Pragmatic treatment options for depression and anxiety disorders are needed.

World psychiatry : official journal of the World Psychiatric Association (WPA)

Andrews G, Hobbs MJ.
PMID: 27717253
World Psychiatry. 2016 Oct;15(3):241-242. doi: 10.1002/wps.20364.

No abstract available.

Cite
Andrews G, Hobbs MJ. Pragmatic treatment options for depression and anxiety disorders are needed. World Psychiatry. 2016;15(3):241-242doi: 10.1002/wps.20364.
Andrews, G., & Hobbs, M. J. (2016). Pragmatic treatment options for depression and anxiety disorders are needed. World psychiatry : official journal of the World Psychiatric Association (WPA), 15(3), 241-242. https://doi.org/10.1002/wps.20364
Andrews, Gavin, and Hobbs, Megan J. "Pragmatic treatment options for depression and anxiety disorders are needed." World psychiatry : official journal of the World Psychiatric Association (WPA) vol. 15,3 (2016): 241-242. doi: https://doi.org/10.1002/wps.20364
Andrews G, Hobbs MJ. Pragmatic treatment options for depression and anxiety disorders are needed. World Psychiatry. 2016 Oct;15(3):241-242. doi: 10.1002/wps.20364. PMID: 27717253; PMCID: PMC5032497.
Copy Download .nbib Format: NLM
Complement fragments suppress lymphocyte immune responses.

Immunology today

Weiler JM, Ballas ZK, Needleman BW, Hobbs MV, Feldbush TL.
PMID: 25290053
Immunol Today. 1982 Sep;3(9):238-43. doi: 10.1016/0167-5699(82)90009-3.

There has been controversy as to whether complement augments immune responses or inhibits them. In this article John Weiler and his colleagues discuss recent evidence that complement fragments can inhibit immune responses that depend upon cellular proliferation.

Cite
Weiler JM, Ballas ZK, Needleman BW, et al. Complement fragments suppress lymphocyte immune responses. Immunol Today. 1982;3(9):238-43doi: 10.1016/0167-5699(82)90009-3.
Weiler, J. M., Ballas, Z. K., Needleman, B. W., Hobbs, M. V., & Feldbush, T. L. (1982). Complement fragments suppress lymphocyte immune responses. Immunology today, 3(9), 238-43. https://doi.org/10.1016/0167-5699(82)90009-3
Weiler, J M, et al. "Complement fragments suppress lymphocyte immune responses." Immunology today vol. 3,9 (1982): 238-43. doi: https://doi.org/10.1016/0167-5699(82)90009-3
Weiler JM, Ballas ZK, Needleman BW, Hobbs MV, Feldbush TL. Complement fragments suppress lymphocyte immune responses. Immunol Today. 1982 Sep;3(9):238-43. doi: 10.1016/0167-5699(82)90009-3. PMID: 25290053.
Copy Download .nbib Format: NLM
Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency.

Journal of clinical medicine

Tucker RM, Ryan S, Hayee BH, Bjarnason I, Augustin AD, Umamahesan C, Taylor D, Weller C, Dobbs SM, Dobbs RJ, Charlett A.
PMID: 32575365
J Clin Med. 2020 Jun 19;9(6). doi: 10.3390/jcm9061916.

Depression is associated with constipation within and outside Parkinson's disease (PD). Since inefficient cognitive-processing (bradyphrenia) features in PD and an enterokinetic agent improved cognitive performance in healthy individuals, bradyphrenia may be associated with constipation. We aim to define the...

Cite
Tucker RM, Ryan S, Hayee BH, et al. Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency. J Clin Med. 2020;9(6)doi: 10.3390/jcm9061916.
Tucker, R. M., Ryan, S., Hayee, B. H., Bjarnason, I., Augustin, A. D., Umamahesan, C., Taylor, D., Weller, C., Dobbs, S. M., Dobbs, R. J., & Charlett, A. (2020). Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency. Journal of clinical medicine, 9(6), . https://doi.org/10.3390/jcm9061916
Tucker, Rosalind M, et al. "Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency." Journal of clinical medicine vol. 9,6 (2020). doi: https://doi.org/10.3390/jcm9061916
Tucker RM, Ryan S, Hayee BH, Bjarnason I, Augustin AD, Umamahesan C, Taylor D, Weller C, Dobbs SM, Dobbs RJ, Charlett A. Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency. J Clin Med. 2020 Jun 19;9(6). doi: 10.3390/jcm9061916. PMID: 32575365; PMCID: PMC7356098.
Copy Download .nbib Format: NLM
The genetics of isolated and syndromic clubfoot.

Journal of children's orthopaedics

Sadler B, Gurnett CA, Dobbs MB.
PMID: 31312262
J Child Orthop. 2019 Jun 01;13(3):238-244. doi: 10.1302/1863-2548.13.190063.

PURPOSE: Congenital clubfoot is a serious birth defect that affects nearly 0.1% of all births. Though there is strong evidence for a genetic basis of isolated clubfoot, aside from a handful of associations, much of the heritability remains unexplained.METHODS:...

Cite
Sadler B, Gurnett CA, Dobbs MB. The genetics of isolated and syndromic clubfoot. J Child Orthop. 2019;13(3):238-244doi: 10.1302/1863-2548.13.190063.
Sadler, B., Gurnett, C. A., & Dobbs, M. B. (2019). The genetics of isolated and syndromic clubfoot. Journal of children's orthopaedics, 13(3), 238-244. https://doi.org/10.1302/1863-2548.13.190063
Sadler, B, et al. "The genetics of isolated and syndromic clubfoot." Journal of children's orthopaedics vol. 13,3 (2019): 238-244. doi: https://doi.org/10.1302/1863-2548.13.190063
Sadler B, Gurnett CA, Dobbs MB. The genetics of isolated and syndromic clubfoot. J Child Orthop. 2019 Jun 01;13(3):238-244. doi: 10.1302/1863-2548.13.190063. PMID: 31312262; PMCID: PMC6598048.
Copy Download .nbib Format: NLM
Evidence Supporting Selective Dorsal Rhizotomy for Treatment of Spastic Cerebral Palsy.

Cureus

Park TS, Dobbs MB, Cho J.
PMID: 30585282
Cureus. 2018 Oct 19;10(10):e3466. doi: 10.7759/cureus.3466.

The objective of this review is to analyze the evidence supporting selective dorsal rhizotomy (SDR) for the treatment of spastic cerebral palsy (CP). We reviewed 85 outcome studies from 12 countries between 1990 and 2017. The published results are...

Cite
Park TS, Dobbs MB, Cho J. Evidence Supporting Selective Dorsal Rhizotomy for Treatment of Spastic Cerebral Palsy. Cureus. 2018;10(10):e3466doi: 10.7759/cureus.3466.
Park, T. S., Dobbs, M. B., & Cho, J. (2018). Evidence Supporting Selective Dorsal Rhizotomy for Treatment of Spastic Cerebral Palsy. Cureus, 10(10), e3466. https://doi.org/10.7759/cureus.3466
Park, T S, et al. "Evidence Supporting Selective Dorsal Rhizotomy for Treatment of Spastic Cerebral Palsy." Cureus vol. 10,10 (2018): e3466. doi: https://doi.org/10.7759/cureus.3466
Park TS, Dobbs MB, Cho J. Evidence Supporting Selective Dorsal Rhizotomy for Treatment of Spastic Cerebral Palsy. Cureus. 2018 Oct 19;10(10):e3466. doi: 10.7759/cureus.3466. PMID: 30585282; PMCID: PMC6300384.
Copy Download .nbib Format: NLM
Functional Outcome of Adulthood Selective Dorsal Rhizotomy for Spastic Diplegia.

Cureus

Park TS, Uhm SY, Walter DM, Meyer NL, Dobbs MB.
PMID: 31565593
Cureus. 2019 Jul 21;11(7):e5184. doi: 10.7759/cureus.5184.

Objective The medical evidence supporting the efficacy of selective dorsal rhizotomy (SDR) on children with spastic diplegia is strong. However, the outcome of SDR on adults with spastic diplegia remains undetermined. The aim is to study the effectiveness and...

Cite
Park TS, Uhm SY, Walter DM, et al. Functional Outcome of Adulthood Selective Dorsal Rhizotomy for Spastic Diplegia. Cureus. 2019;11(7):e5184doi: 10.7759/cureus.5184.
Park, T. S., Uhm, S. Y., Walter, D. M., Meyer, N. L., & Dobbs, M. B. (2019). Functional Outcome of Adulthood Selective Dorsal Rhizotomy for Spastic Diplegia. Cureus, 11(7), e5184. https://doi.org/10.7759/cureus.5184
Park, T S, et al. "Functional Outcome of Adulthood Selective Dorsal Rhizotomy for Spastic Diplegia." Cureus vol. 11,7 (2019): e5184. doi: https://doi.org/10.7759/cureus.5184
Park TS, Uhm SY, Walter DM, Meyer NL, Dobbs MB. Functional Outcome of Adulthood Selective Dorsal Rhizotomy for Spastic Diplegia. Cureus. 2019 Jul 21;11(7):e5184. doi: 10.7759/cureus.5184. PMID: 31565593; PMCID: PMC6758990.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in medicine

Augustin AD, Savio A, Nevel A, Ellis RJ, Weller C, Taylor D, Tucker RM, Ibrahim MAA, Bjarnason I, Dobbs SM, Dobbs RJ, Charlett A.
PMID: 31555648
Front Med (Lausanne). 2019 Aug 28;6:188. doi: 10.3389/fmed.2019.00188. eCollection 2019.

No abstract available.

Cite
Augustin AD, Savio A, Nevel A, et al. . Front Med (Lausanne). 2019;6:188doi: 10.3389/fmed.2019.00188.
Augustin, A. D., Savio, A., Nevel, A., Ellis, R. J., Weller, C., Taylor, D., Tucker, R. M., Ibrahim, M. A. A., Bjarnason, I., Dobbs, S. M., Dobbs, R. J., & Charlett, A. (2019). . Frontiers in medicine, 6188. https://doi.org/10.3389/fmed.2019.00188
Augustin, Aisha D, et al. "." Frontiers in medicine vol. 6 (2019): 188. doi: https://doi.org/10.3389/fmed.2019.00188
Augustin AD, Savio A, Nevel A, Ellis RJ, Weller C, Taylor D, Tucker RM, Ibrahim MAA, Bjarnason I, Dobbs SM, Dobbs RJ, Charlett A. . Front Med (Lausanne). 2019 Aug 28;6:188. doi: 10.3389/fmed.2019.00188. eCollection 2019. PMID: 31555648; PMCID: PMC6724659.
Copy Download .nbib Format: NLM
Blast and accelerated phase CML: room for improvement.

Hematology. American Society of Hematology. Education Program

How J, Venkataraman V, Hobbs GS.
PMID: 34889372
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):122-128. doi: 10.1182/hematology.2021000240.

Tyrosine kinase inhibitors (TKIs) revolutionized the treatment of chronic myeloid leukemia (CML). With TKI therapy, the percentage of patients who progress to accelerated phase (AP) or blast phase (BP) CML has decreased from more than 20% to 1% to...

Cite
How J, Venkataraman V, Hobbs GS. Blast and accelerated phase CML: room for improvement. Hematology Am Soc Hematol Educ Program. 2021;2021(1):122-128doi: 10.1182/hematology.2021000240.
How, J., Venkataraman, V., & Hobbs, G. S. (2021). Blast and accelerated phase CML: room for improvement. Hematology. American Society of Hematology. Education Program, 2021(1), 122-128. https://doi.org/10.1182/hematology.2021000240
How, Joan, et al. "Blast and accelerated phase CML: room for improvement." Hematology. American Society of Hematology. Education Program vol. 2021,1 (2021): 122-128. doi: https://doi.org/10.1182/hematology.2021000240
How J, Venkataraman V, Hobbs GS. Blast and accelerated phase CML: room for improvement. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):122-128. doi: 10.1182/hematology.2021000240. PMID: 34889372.
Copy Download .nbib Format: NLM
Validation of a Home Food Environment Instrument Assessing Household Food Patterning and Quality.

Nutrients

Barrett KJ, Hibbs-Shipp SK, Hobbs S, Boles RE, Johnson SL, Bellows LL.
PMID: 34836185
Nutrients. 2021 Nov 03;13(11). doi: 10.3390/nu13113930.

The home food environment (HFE) is associated with dietary intake; yet measuring HFE quality often requires burdensome collection of detailed inventories. This project evaluated the capacity of the Home Inventory to Describe Eating and Activity, version 2 (Home-IDEA2) to...

Cite
Barrett KJ, Hibbs-Shipp SK, Hobbs S, et al. Validation of a Home Food Environment Instrument Assessing Household Food Patterning and Quality. Nutrients. 2021;13(11)doi: 10.3390/nu13113930.
Barrett, K. J., Hibbs-Shipp, S. K., Hobbs, S., Boles, R. E., Johnson, S. L., & Bellows, L. L. (2021). Validation of a Home Food Environment Instrument Assessing Household Food Patterning and Quality. Nutrients, 13(11), . https://doi.org/10.3390/nu13113930
Barrett, Katherine J, et al. "Validation of a Home Food Environment Instrument Assessing Household Food Patterning and Quality." Nutrients vol. 13,11 (2021). doi: https://doi.org/10.3390/nu13113930
Barrett KJ, Hibbs-Shipp SK, Hobbs S, Boles RE, Johnson SL, Bellows LL. Validation of a Home Food Environment Instrument Assessing Household Food Patterning and Quality. Nutrients. 2021 Nov 03;13(11). doi: 10.3390/nu13113930. PMID: 34836185; PMCID: PMC8619541.
Copy Download .nbib Format: NLM
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.

American journal of hematology

Mellors PW, Kourelis T, Go RS, Muchtar E, Gertz MA, Kumar SK, Buadi FK, Kapoor P, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Warsame R, Leung NR, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Dispenzieri A.
PMID: 34822175
Am J Hematol. 2022 Feb 01;97(2):209-215. doi: 10.1002/ajh.26422. Epub 2021 Nov 30.

Thromboses are prevalent in POEMS syndrome, but few risk factors for POEMS-associated thrombosis have been identified. The objective of this study is to identify novel risk factors for POEMS-associated thrombosis. In this retrospective cohort of 230 POEMS patients, 27%...

Cite
Mellors PW, Kourelis T, Go RS, et al. Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients. Am J Hematol. 2021;97(2):209-215doi: 10.1002/ajh.26422.
Mellors, P. W., Kourelis, T., Go, R. S., Muchtar, E., Gertz, M. A., Kumar, S. K., Buadi, F. K., Kapoor, P., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Warsame, R., Leung, N. R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., & Dispenzieri, A. (2022). Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients. American journal of hematology, 97(2), 209-215. https://doi.org/10.1002/ajh.26422
Mellors, Patrick W, et al. "Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients." American journal of hematology vol. 97,2 (2022): 209-215. doi: https://doi.org/10.1002/ajh.26422
Mellors PW, Kourelis T, Go RS, Muchtar E, Gertz MA, Kumar SK, Buadi FK, Kapoor P, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Warsame R, Leung NR, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Dispenzieri A. Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients. Am J Hematol. 2022 Feb 01;97(2):209-215. doi: 10.1002/ajh.26422. Epub 2021 Nov 30. PMID: 34822175; PMCID: PMC8738145.
Copy Download .nbib Format: NLM
Waldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management.

Journal of the advanced practitioner in oncology

Hobbs M, Fonder A, Hwa YL.
PMID: 33604098
J Adv Pract Oncol. 2020 May-Jun;11(4):381-389. doi: 10.6004/jadpro.2020.11.4.5. Epub 2020 May 01.

Waldenström macroglobulinemia is a rare hematologic malignancy characterized by an IgM-associated lymphoplasmacytic lymphoma. Often, it is associated with an indolent disease course, and many patients are candidates for careful monitoring. As many patients present with advanced age and nonspecific...

Cite
Hobbs M, Fonder A, Hwa YL. Waldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management. J Adv Pract Oncol. 2020;11(4):381-389doi: 10.6004/jadpro.2020.11.4.5.
Hobbs, M., Fonder, A., & Hwa, Y. L. (2020). Waldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management. Journal of the advanced practitioner in oncology, 11(4), 381-389. https://doi.org/10.6004/jadpro.2020.11.4.5
Hobbs, Miriam, et al. "Waldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management." Journal of the advanced practitioner in oncology vol. 11,4 (2020): 381-389. doi: https://doi.org/10.6004/jadpro.2020.11.4.5
Hobbs M, Fonder A, Hwa YL. Waldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management. J Adv Pract Oncol. 2020 May-Jun;11(4):381-389. doi: 10.6004/jadpro.2020.11.4.5. Epub 2020 May 01. PMID: 33604098; PMCID: PMC7863125.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 201 entries